Antibiotics to prevent infections in hemodialysis catheters
Part of Infections, Kidney & urinary clinical trials.
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have end-stage kidney disease needing hemodialysis.
- Use a catheter (a tube in a vein) for chronic hemodialysis—either a cuffed or uncuffed CVC.
- Be able to understand the study and sign written consent.
- You must not have a known allergy or intolerance to beta-lactam antibiotics or clindamycin.
- You should not currently have an active infection that is being treated with antibiotics.
- You cannot be pregnant or breastfeeding during the study; if you could become pregnant, you must use approved birth control starting at least 1 month before and during the 6 months of treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an antibiotic after a kidney transplant can prevent bloodstream infections. Participants who have bacteria in their urine in the first month after transplant may be eligible.
This study tests if giving antibiotics before placing a dialysis catheter can prevent infections. It may help people with heart conditions or those who need a catheter in the leg.
This study tests whether putting a small cap containing chlorhexidine (a germ-killing medicine) on the end of the dialysis catheter can prevent serious bloodstream infections. If you are on dialysis with a catheter, this may help reduce your risk of infection.
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
This study tests whether adding a low dose of a blood thinner called apixaban (also known as Eliquis) to the standard solution used to keep dialysis catheters open will help prevent them from getting blocked. It could improve the reliability of your dialysis treatments and reduce the need for catheter replacements.
This Phase 3 study tests whether a medicine-filled “lock” put into a dialysis catheter can lower the risk of infections. It is meant for people on regular dialysis with a tunnelled catheter who already have it in place.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.